Peter G Kaufmann Selected Research

Sertraline (Zoloft)

7/2004

Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter G Kaufmann Research Topics

Disease

3	Weight Loss (Weight Reduction) 11/2021 - 01/2019
2	Hypertension (High Blood Pressure) 01/2017 - 07/2004
2	Infarction (Infarctions) 01/2017 - 06/2003
2	Myocardial Infarction 07/2005 - 07/2004
2	Coronary Disease (Coronary Heart Disease) 07/2005 - 07/2004
1	COVID-19 08/2023
1	Type 2 Diabetes Mellitus (MODY) 06/2020
1	Acute Coronary Syndrome 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2005

Drug/Important Bio-Agent (IBA)

3	4-nitro-3-dimethylaminopropiophenoneIBA 11/2021 - 01/2019
3	Antidepressive Agents (Antidepressants)IBA 07/2005 - 06/2003
1	COVID-19 VaccinesIBA 08/2023
1	CholesterolIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Sertraline (Zoloft)FDA LinkGeneric 07/2004
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2003

Therapy/Procedure

1	Stents 01/2017